← Open Payments lookup

ALISON ELSHEIKH: Open Payments

NPI 1942841242 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$449 in 21 payments from 10 companies in 2025. Trend: 2023 $99 · 2024 $407 · 2025 $449

Food & beverage: $449
CompanyPaymentsAmount
ABBVIE INC.8$160
AstraZeneca Pharmaceuticals LP3$68
Lilly USA, LLC2$47
Braeburn Inc.2$40
Neurocrine BioSciences, Inc.1$31
Indivior Inc.1$27
Lundbeck LLC1$25
Novo Nordisk Inc1$20
GlaxoSmithKline, LLC.1$16
Amgen Inc.1$14

Products named: VRAYLAR, AIRSUPRA, QULIPTA, BRIXADI, CRENESSITY, ZEPBOUND, SUBLOCADE, REXULTI.

Industry payments across NY — which companies pay providers there.